INTERMUNE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 39216
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1283
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
  
 
C07K PEPTIDES 2134
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
A61J CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 129
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0314,074 LPA-ASSOCIATED PROTEIN AND RNA EXPRESSIONNov 15, 16Nov 02, 17[C12Q]
2017/0100,380 PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT 5-METHYL-1-PHENYL-2-(1H)-PYRIDONEDec 20, 16Apr 13, 17[A61K]
2015/0164,874 PIRFENIDONE AND ANTI-FIBROTIC THERAPY IN SELECTED PATIENTSMay 25, 12Jun 18, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9726677 Proteomic IPF markersMar 14, 14Aug 08, 17[A61K, C12Q, G01N]
9682071 Methods of improving microvascular integrityMar 13, 14Jun 20, 17[A61K]
9675593 Anti-fibrotic pyridinonesMay 23, 16Jun 13, 17[A61K, C07D]
9561217 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneNov 24, 15Feb 07, 17[A61K, C07D]
9527816 Method of modulating stress-activated protein kinase systemApr 28, 14Dec 27, 16[A61K, C07H, C07D]
9359379 Anti-fibrotic pyridinonesOct 01, 13Jun 07, 16[A61K, C07D]
9290450 Compounds and methods for treating inflammatory and fibrotic disordersApr 28, 14Mar 22, 16[C07D]
9017722 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneOct 26, 12Apr 28, 15[A61K, C07D]
8975235 Lysophosphatidic acid receptor antagonistsAug 14, 12Mar 10, 15[A61K, C07H, C07D]
8969347 Compounds and methods for treating inflammatory and fibrotic disordersOct 15, 12Mar 03, 15[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0100,381 PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTIONAbandonedDec 22, 16Apr 13, 17[A61K]
2017/0079,969 Methods of Administering Pirfenidone TherapyAbandonedDec 01, 16Mar 23, 17[A61K]
2016/0324,842 METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENTAbandonedJul 18, 16Nov 10, 16[A61J, A61K]
2016/0250,198 Pirfenidone Treatment for Patients with Atypical Liver FunctionAbandonedMay 06, 16Sep 01, 16[A61K]
2016/0228,423 Methods of Administering Pirfenidone TherapyAbandonedApr 13, 16Aug 11, 16[A61K]
2015/0368,200 METHOD FOR SYNTHESIZING PIRFENIDONEAbandonedAug 20, 15Dec 24, 15[C07D]
2015/0342,941 PIRFENIDONE THERAPY AND INDUCERS OF CYTOCHROME P450AbandonedAug 13, 15Dec 03, 15[A61K]
2015/0209,341 PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT 5-METHYL -1-PHENYL-2-(1H)-PYRIDONEAbandonedMar 27, 15Jul 30, 15[A61K]
2014/0350,060 Methods of Administering Pirfenidone TherapyAbandonedAug 08, 14Nov 27, 14[A61K]
2014/0242,159 Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable ExcipientsAbandonedMay 07, 14Aug 28, 14[A61K]
2014/0221,434 ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPYAbandonedApr 07, 14Aug 07, 14[A61K]
2014/0221,660 METHOD FOR SYNTHESIZING PIRFENIDONEAbandonedApr 08, 14Aug 07, 14[C07D]
2014/0213,538 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTSAbandonedJan 15, 14Jul 31, 14[C07H, A61K, C07D]
2014/0200,215 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTSAbandonedMar 12, 13Jul 17, 14[C07D]
2014/0094,456 ANTI-FIBROTIC PYRIDINONESAbandonedMar 13, 13Apr 03, 14[C07D]
2014/0073,673 Pirfenidone Treatment for Patients with Atypical Liver FunctionAbandonedNov 12, 13Mar 13, 14[A61K]
2013/0345,430 METHOD FOR SYNTHESIZING PIRFENIDONEAbandonedJul 22, 13Dec 26, 13[C07D]
2013/0220,871 METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENTAbandonedApr 11, 13Aug 29, 13[A61J, A61K]
2013/0225,639 ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPYAbandonedApr 05, 13Aug 29, 13[A61K]
2013/0150,426 METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSISAbandonedNov 21, 12Jun 13, 13[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.